Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,651 signal articles · 110 in last 24h · 122,880 total before filter · latest 52m ago
110last 24h
1239last 7d
207● bullish (7d)
145● bearish (7d)
205publishers
AllMacro205Earnings416M&A103Regulatory24Product12Analyst10
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Texas Pacific (TPL) Beats Q1 Earnings Estimates
Zacks109d agobullish
Texas Pacific (TPL) Beats Q1 Earnings Estimates

Texas Pacific (TPL) delivered earnings and revenue surprises of +1.97% and -2.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

LegalZoom (LZ) Q1 Earnings Lag Estimates
Zacks109d agoneutral
LegalZoom (LZ) Q1 Earnings Lag Estimates

LegalZoom (LZ) delivered earnings and revenue surprises of -10.45% and +2.17%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Coherent (COHR) Q3 Earnings Match Estimates
Zacks109d agoneutral
Coherent (COHR) Q3 Earnings Match Estimates

Coherent (COHR) delivered earnings and revenue surprises of +0.24% and +1.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Bristol Myers Squibb World Cup Push Meets Valuation And Earnings Questions
Simply Wall St.109d agoneutral
Bristol Myers Squibb World Cup Push Meets Valuation And Earnings Questions

Bristol-Myers Squibb, NYSE:BMY, has launched a new patient-focused "Won't Lose" media campaign ahead of the FIFA World Cup 2026. The campaign highlights the company’s focus on breakthrough medicines and resilience in the fight against serious diseases. The initiative is set to run nationwide across digital and social platforms and will feature high profile sports personalities. Bristol-Myers Squibb, NYSE:BMY, is putting fresh attention on its brand with "Won't Lose," a broad media effort...

First Lumentum, Now Coherent. Why Earnings Aren’t Boosting the AI Laser Stock.
Barrons.com109d agoneutral
First Lumentum, Now Coherent. Why Earnings Aren’t Boosting the AI Laser Stock.

Coherent reported quarterly earnings that were in-line with Wall Street’s expectations, with gross margins increasing slightly. The optical networking company is benefiting from the artificial intelligence data center boom—but shares fell anyway. Coherent posted adjusted earnings of $1.41 a share for the fiscal third-quarter, compared to 91 cents a year ago and Wall Street’s $1.40 a share prediction.

Hecla (HL) Q3 2025 Earnings Call Transcript
Motley Fool109d agoneutral
Hecla (HL) Q3 2025 Earnings Call Transcript

Robert Krcmarov: Thank you, Mike, and good morning, everyone. Let me just start by reminding you why Hecla stands apart in the silver sector. As the oldest silver company on the New York Stock Exchange with a history dating back 134 years, we operate exclusively in the premier jurisdictions of the United States and Canada.

Investing.com109d agobearish
Snap falls 3% on in-line second quarter guidance

Investing.com - Snap Inc. (NYSE:SNAP) reported first quarter results that exceeded analyst expectations, but shares fell 3% as the company’s second quarter revenue guidance came in roughly in line with Wall Street estimates.

AppLovin Stock Jumps, Then Reverses, Following Q1 Results
Investor's Business Daily109d agoneutral
AppLovin Stock Jumps, Then Reverses, Following Q1 Results

AppLovin reported first-quarter results that beat top- and bottom-line expectations. AppLovin helps mobile app developers find new users and sell advertising in their apps. AppLovin expects sales of $1.93 billion, based on the midpoint of its guidance range.

SolarEdge Technologies Q1 Earnings Call Highlights
MarketBeat109d agoneutral
SolarEdge Technologies Q1 Earnings Call Highlights

SolarEdge Technologies (NASDAQ:SEDG) reported first-quarter 2026 results that management said showed continued progress in its push toward “profitable growth,” alongside product launches and efforts to expand market share across key regions. On the earnings call, CEO Shuki Nir said 2026 is a “year o

Recursion Pharmaceuticals Q1 Earnings Call Highlights
MarketBeat109d agoneutral
Recursion Pharmaceuticals Q1 Earnings Call Highlights

Recursion Pharmaceuticals (NASDAQ:RXRX) leadership used its latest earnings call to emphasize a sharper focus on translating artificial intelligence-enabled discovery into clinical and partnership “proof points,” while maintaining what it described as tighter financial discipline. CEO and President

Novavax Q1 Earnings Call Highlights
MarketBeat109d agoneutral
Novavax Q1 Earnings Call Highlights

Novavax (NASDAQ:NVAX) executives used the company’s first-quarter 2026 earnings call to highlight continued progress in reshaping the business around partner-driven revenue, a leaner operating model, and selective internal R&D designed to seed additional collaborations. Strategy centered on par

One Stop Systems Q1 Earnings Call Highlights
MarketBeat109d agoneutral
One Stop Systems Q1 Earnings Call Highlights

One Stop Systems (NASDAQ:OSS) reported a strong start to 2026, posting significant year-over-year gains in both revenue and profitability as demand increased for its ruggedized, enterprise-class compute platforms across defense and commercial markets. Management also reaffirmed full-year guidance, c